Search Results 321-330 of 11528 for VEO-IBD
Participation eligibility · Individuals < 18 years. · History of IBD (Crohn's disease or ulcerative colitis), microscopic colitis, or celiac disease. · Pregnancy.
About this study. This is a two-cohort, multicenter, open-label study of MOR00208 combined with idelalisib or venetoclax in adult patients with R/R CLL or ...
The general aim of this study is to estimate the rate of disease progression for adults who seek testing and test positive for SARS-CoV-2. The primary endpoint ...
The purpose of this study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and ...
Vismodegib is used to treat metastatic basal cell carcinoma, a certain type of skin cancer that has already spread through the body. It also treats advanced ...
This study aims to determine the efficacy of CPI-0610 + ruxolitinib compared with placebo + ruxolitinibin patients with naive myelofibrosis (MF). Participation ...
Learn how Mayo Clinic's Neuro-Informatics Lab, led by Mohamad Bydon, M.D., studies the impact and safety of surgical and nonsurgical interventions.
Colonoscopy, Flexible sigmoidoscopy, Upper endoscopy, Ulcerative colitis, Inflammatory bowel disease, Crohn's disease, ... ... Inflammatory bowel disease (IBD) ...
The purpose of this study is to establish the clinical performance of the Medfrontier Intact FGF23 immunoassay in patients with tumor induced osteomalacia (TIO) ...
Arthritis associated with inflammatory bowel disease;; Undifferentiated spondyloarthritis;; Systemic lupus erythematosus;; Sjogren's syndrome;; Scleroderma ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.